OncoTargets and Therapy
Volume 14, 2021 - Issue
Open access
84
Views
4
CrossRef citations to date
0
Altmetric
Case Report
Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report
Xinjia Ding1 Department of Urology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People’s Republic of ChinaView further author information
, Jianguo Zong2 The Institute for Translational Medicine, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People’s Republic of ChinaView further author information
, Xiang Li2 The Institute for Translational Medicine, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People’s Republic of ChinaView further author information
, Xiaoyan Bai2 The Institute for Translational Medicine, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People’s Republic of ChinaView further author information
, Bowen Tan2 The Institute for Translational Medicine, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People’s Republic of ChinaView further author information
, Weibing Sun1 Department of Urology, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People’s Republic of China
https://orcid.org/0000-0002-4903-6851View further author information
Ruoyu Wang2 The Institute for Translational Medicine, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People’s Republic of ChinaCorrespondence[email protected]
View further author information
& View further author information
Yan Ding2 The Institute for Translational Medicine, The Affiliated Zhongshan Hospital of Dalian University, Dalian, 116001, People’s Republic of China;3 Department of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, MA, 02115, USACorrespondence[email protected]
https://orcid.org/0000-0002-7708-4391View further author information
Pages 2177-2183
|
Published online: 25 Mar 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.